1056039-85-0 Usage
Pyridine-based compound
The compound has a pyridine ring as its core structure.
Containing a tetrazole
The compound has a 1-methyl-1H-tetrazol-5-yl group attached to the pyridine ring.
Containing a boron-containing group
The compound has a 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group attached to the pyridine ring.
Used in organic synthesis and medicinal chemistry
The compound is often used as a building block for the development of pharmaceuticals, agrochemicals, and materials.
Employed as a ligand in transition metal catalyzed processes
The compound is commonly used to modify the properties of transition metals in chemical reactions.
Versatile chemical structure and reactivity
The compound's structure and reactivity allow for a diverse range of applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1056039-85-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,6,0,3 and 9 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1056039-85:
(9*1)+(8*0)+(7*5)+(6*6)+(5*0)+(4*3)+(3*9)+(2*8)+(1*5)=140
140 % 10 = 0
So 1056039-85-0 is a valid CAS Registry Number.
1056039-85-0Relevant articles and documents
ANTIMICROBIAL INDOLINE COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS
-
Page/Page column 22-23, (2010/04/23)
The present invention provides indoline heterocyclic compounds of the following formula I: or pharmaceutically acceptable salts, prodrugs, solvates, or hydrates thereof useful as antibacterial agents, pharmaceutical compositions containing them, methods f
ANTIMICROBIAL HETEROCYCLIC COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS
-
Page/Page column 54, (2008/12/08)
The present invention provides heterocyclic compounds of the following formula (I) : or pharmaceutically acceptable salts, prodrugs, solvates, or hydrates thereof useful as antibacterial agents, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
CYCLOPROPYL GROUP SUBSTITUTED OXAZOLIDINONE ANTIBIOTICS AND DERIVATIVES THEREOF
-
Page 50, (2008/06/13)
This invention relates to new oxazolidinones having a cyclopropyl moiety, which are effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci, Bacteroides spp., Clostridia spp. species, as well as